Mesalamine delivery systems: do they really make much difference?
- 6 January 2005
- journal article
- research article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 57 (2), 281-302
- https://doi.org/10.1016/j.addr.2004.08.008
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitisGastroenterology, 1998
- Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitisDigestive Diseases and Sciences, 1995
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Localization of Drug Release Sites from an Oral Sustained‐Release Formulation of 5‐ASA (Pentasa®) in the Gastrointestinal Tract Using Gamma ScintigraphyThe Journal of Clinical Pharmacology, 1993
- Balsalazide in the maintenance treatment of patients with ulcerative colitis, a double‐blind comparison with sulphasalazineAlimentary Pharmacology & Therapeutics, 1988
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisNew England Journal of Medicine, 1987
- Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using99mTc-labeled 5-ASA suppositoriesDigestive Diseases and Sciences, 1987
- SulfasalazineDigestive Diseases and Sciences, 1983
- Studies of two novel sulfasalazine analogs, ipsalazide and balsalazideDigestive Diseases and Sciences, 1983
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980